Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery

Figure 4 Sarcopenia was associated with an increased three year mortality. A: The presence of sarcopenia was also associated with the risk of death (no sarcopenia, 18.0 mo; 40.0% vs sarcopenia, 13.7 mo; 23.0% vs median, 3-yr survival, respectively; P = 0.01) in patients undergoing pancreatic surgery. Used with permission Peng et al[45], 2012; B: The overall survival according to total psoas volume stratified by sarcopenia patients vs no sarcopenia patients quartiles in patients undergoing pancreatic surgeries. Used with permission Amini et al[47], 2015.